Mallik Manaswinee, Singhai Abhishek, Khadanga Sagar, Ingle Vaibhav
Medicine, All India Institute of Medical Sciences, Bhopal, Bhopal, IND.
Internal Medicine, All India Institute of Medical Sciences, Bhopal, Bhopal, IND.
Cureus. 2022 Jan 14;14(1):e21226. doi: 10.7759/cureus.21226. eCollection 2022 Jan.
Cirrhosis progression varies greatly from patient to patient due to a variety of factors, including hepatic reserve, cirrhosis etiology, and the presence of hepatocellular cancer. As a result, determining a prognosis in a patient with cirrhosis remains a difficult task. For nearly three decades, the Child-Pugh score (CPS) has been the gold standard for determining the prognosis of cirrhosis. In the last two decades, many prognostic models and scores like a model for end-stage liver disease (MELD), chronic liver failure-sequential organ failure assessment (CLIF-SOFA) score, peripheral blood lymphocyte to monocyte ratio (LMR) have been presented to predict prognosis in patients with cirrhosis and to choose the best therapy option. The aim of our study is to determine which score is more effective in predicting three-month mortality and whether these scores are equally effective in predicting short-term outcomes.
MATERIALS & METHODS: In this hospital-based longitudinal study, we analyzed 140 patients with cirrhosis of liver visiting All India Institute of Medical Sciences Bhopal between July 2019 and July 2020. All the 140 patients were followed up for three months to establish short-term outcomes. The blood investigations were done at the time of presentation from all the patients and after three months in the survivors. Various scores were calculated.
The majority of patients (47%) were in Child-Pugh class C. Mean MELD score was 13.54, LMR score was 1.96 and CLIF-SOFA score was 5. The total bilirubin, serum creatinine, international normalized ratio (INR), total leukocyte count, absolute monocyte count, CPS, MELD, CLIF-SOFA were significantly higher in a non-surviving group as compared to the surviving group, whereas the albumin and LMR significantly decreased in the non-surviving group. On performing multivariate regression, LMR and CLIF-SOFA were significant independent risk factors of mortality after adjusting for confounding factors. All the parameters had significant discriminatory power to predict mortality. Discriminatory power of CLIF-SOFA (AUC 0.808; 95% CI: 0.733 to 0.870) was excellent and discriminatory power of CPS (AUC 0.792; 95% CI: 0.716 to 0.856), MELD score (AUC 0.765; 95% CI: 0.685 to 0.832) and LMR (AUC 0.75; 95% CI: 0.669 to 0.819) was acceptable. Among all the parameters, CLIF-SOFA was the best predictor of mortality at a cut-off point of >5 with 80.80% chances of correctly predicting mortality.
The significant morbidity and mortality indicators are high total bilirubin, high creatinine, high INR, high TLC, low platelet count, and low albumin. Among the various scores, CLIF-SOFA is a better predictor of mortality and morbidity. Low LMR and high CLIF-SOFA are significant independent risk factors of mortality at three months.
由于多种因素,包括肝脏储备、肝硬化病因以及肝细胞癌的存在,肝硬化的进展在患者之间差异很大。因此,确定肝硬化患者的预后仍然是一项艰巨的任务。近三十年来,Child-Pugh评分(CPS)一直是确定肝硬化预后的金标准。在过去二十年中,已经提出了许多预后模型和评分,如终末期肝病模型(MELD)、慢性肝衰竭-序贯器官衰竭评估(CLIF-SOFA)评分、外周血淋巴细胞与单核细胞比值(LMR),以预测肝硬化患者的预后并选择最佳治疗方案。我们研究的目的是确定哪种评分在预测三个月死亡率方面更有效,以及这些评分在预测短期结局方面是否同样有效。
在这项基于医院的纵向研究中,我们分析了2019年7月至2020年7月期间在博帕尔全印度医学科学研究所就诊的140例肝硬化患者。对所有140例患者进行了三个月的随访以确定短期结局。在所有患者就诊时以及幸存者三个月后进行血液检查。计算了各种评分。
大多数患者(47%)处于Child-Pugh C级。平均MELD评分为13.54,LMR评分为1.96,CLIF-SOFA评分为5。与存活组相比,非存活组的总胆红素、血清肌酐、国际标准化比值(INR)、白细胞总数、绝对单核细胞计数、CPS、MELD、CLIF-SOFA显著更高,而非存活组的白蛋白和LMR显著降低。进行多变量回归后,LMR和CLIF-SOFA在调整混杂因素后是死亡率的显著独立危险因素。所有参数对预测死亡率都有显著的判别能力。CLIF-SOFA的判别能力(AUC 0.808;95%CI:0.733至0.870)极佳,CPS(AUC 0.792;95%CI:0.716至0.856)、MELD评分(AUC 0.765;95%CI:0.685至0.832)和LMR(AUC 0.75;95%CI:0.669至0.819)的判别能力可接受。在所有参数中,CLIF-SOFA在截断点>5时是死亡率的最佳预测指标,正确预测死亡率的机会为80.80%。
显著的发病率和死亡率指标是高总胆红素、高肌酐、高INR、高白细胞总数、低血小板计数和低白蛋白。在各种评分中,CLIF-SOFA是死亡率和发病率的更好预测指标。低LMR和高CLIF-SOFA是三个月死亡率的显著独立危险因素。